Effect of orlistat on cardiovascular disease risk in obese adults
Just so you know–it wasn’t me that designated April/May as “beat up the pharmaceuticals for obesity” months.
This study found improvements in several metabolic risk factors for CVD, but not enough to lower 10-year risk assessment. Interestingly, although the patients on orlistat had lower total cholesterol, none reduced their cholesterol lowering meds. I can practically guarantee that lifestyle changes geared towards a healthy body composition will definitely lower a patient’s need for cholesterol lowering drugs.
